| 2019-07 |
Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216 |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 4626. |
|
| 2019-05 |
A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534. |
|
| 2018-12 |
Establishment and characterization of novel syngeneic oral squamous cell carcinoma mouse cell lines |
Cancer Science. 2018 Dec;109(Suppl. 2):386. |
 |
| 2018-07 |
Blockage of EGFR signaling repurposes tumor metabolism through suppression of glycolysis and Kreb cycle in head and neck cancer |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 3944. |
|
| 2018-07 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas inhibit indoleamine 2,3-dioxygenase in vitro and in vivo |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 1664. |
|
| 2018-07 |
Clinical candidate DBPR112: A novel epidermal growth factor receptor inhibitor as a promising treatment for non-small cell lung cancer |
Cancer Research. 2018 Jul;78(13, Suppl.):Meeting Abstract 4789. |
|
| 2016-12 |
Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy |
European Journal of Cancer. 2016 Dec;68(Suppl. 1):S83-S84. |
|
| 2015-08 |
Optimization of furanopyrimidine-based kinase inhibitors: Identification of a BTK kinase inhibitor for the treatment of B cell lymphoma |
Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 180. |
|
| 2015-05 |
Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595. |
|
| 2014-11 |
Cytokine induces MIR-424 expression and modulates SOCS2/STAT5 signaling pathway in oral cancer |
European Journal of Cancer. 2014 Nov;50(Suppl. 6):147. |
|
| 2014-11 |
Discovery of multiple kinases inhibitors, DBPR114, as the novel anti-cancer agent |
European Journal of Cancer. 2014 Nov;50(Suppl. 6):92-93. |
|
| 2014-10 |
Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell |
Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753. |
|
| 2014-05 |
High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522. |
|
